Table 3.
Model 1a | Model 2b | Model 3c | Model 4d | Model 5e | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Beta (SE) | p | Beta (SE) | p | Beta (SE) | p | Beta (SE) | p | Beta (SE) | p | |
African-Americans (n=226) | ||||||||||
0 (ref) | -- | -- | -- | -- | -- | |||||
1 | 0.19 (0.17) | 0.26 | 0.26 (0.17) | 0.12 | 0.29 (0.17) | 0.08 | 0.25 (0.17) | 0.14 | 0.26 (0.17) | 0.12 |
2 | 0.41 (0.16) | 0.01 | 0.52 (0.16) | 0.002 | 0.48 (0.16) | 0.002 | 0.46 (0.16) | 0.003 | 0.44 (0.15) | 0.004 |
Whites (n=978) | ||||||||||
0 (ref) | -- | -- | -- | -- | -- | |||||
1 | 0.04 (0.07) | 0.56 | 0.03 (0.07) | 0.62 | 0.04 (0.07) | 0.57 | 0.03 (0.07) | 0.72 | 0.02 (0.07) | 0.74 |
2 | 0.33 (0.09) | <.001 | 0.31 (0.09) | <.001 | 0.30 (0.09) | <.001 | 0.30 (0.09) | <.001 | 0.29 (0.09) | <.001 |
SE= standard error; MIDUS=Midlife in the United States.
Adjusted for demographics (age, sex, marital status, employment status)
Model 1 + socioeconomic status (education, total household income)
Model 2 + medications (oral steroid, beta-blocker, selective serotonin reuptake inhibitor, cholesterol)
Model 3 + health behaviors covariates (current smoker, physical activity score, past month alcohol usage)
Model 4 + psychosocial characteristics (neuroticism, negative affect)